These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3974940

  • 21. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

  • 22. Peripheral blood flow rates and microvascular responses to orthostatic pressure changes in claudicants before and after revascularisation.
    Midttun M, Sejrsen P, Paaske WP.
    Eur J Vasc Endovasc Surg; 1999 Mar 15; 17(3):225-9. PubMed ID: 10092895
    [Abstract] [Full Text] [Related]

  • 23. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 15; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 24. The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication.
    Panchenko E, Dobrovolsky A, Rogoza A, Sorokin E, Ageeva N, Markova L, Titaeva E, Anuchin V, Karpov Y, Saks V.
    Int Angiol; 1994 Mar 15; 13(1):59-64. PubMed ID: 8077800
    [Abstract] [Full Text] [Related]

  • 25. [Acral skin circulation following intra-arterial infusion of vasodilating substances in patients with intermittent claudication].
    Scheffler A, Rieger H.
    Med Klin (Munich); 1990 Jan 15; 85(1):1-5. PubMed ID: 2314351
    [Abstract] [Full Text] [Related]

  • 26. [Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study].
    Minerva Med; 1985 Oct 13; 76(39):1803-11. PubMed ID: 4047463
    [Abstract] [Full Text] [Related]

  • 27. Rheological activity of propionyl L-carnitine.
    Pola P, Flore R, Tondi P, Nolfe G.
    Drugs Exp Clin Res; 1991 Oct 13; 17(3):191-6. PubMed ID: 1914846
    [Abstract] [Full Text] [Related]

  • 28. [Objectivation of the rheologic and hemodynamic and metabolic effects of ultraviolet irradiation of autologous venous blood in Fontaine type II-IV peripheral arterial occlusive disorders].
    Zwiener U, Belgrad D.
    Z Gesamte Inn Med; 1987 Jan 15; 42(2):44-50. PubMed ID: 3577268
    [Abstract] [Full Text] [Related]

  • 29. Haemodynamic and haemorheological effects of buflomedil in patients with peripheral occlusive arterial disease.
    Perego MA, Sergio G, Espureo M, Francisci A, Artale F.
    Curr Med Res Opin; 1982 Jan 15; 8(3):178-87. PubMed ID: 7128189
    [Abstract] [Full Text] [Related]

  • 30. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C, Antignani PL, Schachter I, Koverech A, Messano M, Virmani A.
    Ann Vasc Surg; 2008 Jan 15; 22(4):552-8. PubMed ID: 18502605
    [Abstract] [Full Text] [Related]

  • 31. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E, Thiele P.
    Z Gesamte Inn Med; 1987 Mar 01; 42(5):137-41. PubMed ID: 3590891
    [Abstract] [Full Text] [Related]

  • 32. Effect of nicotinic acid and dipyridamole on tissue blood flow in peripheral vascular disease.
    Smith RS, Warren DJ.
    Pharmatherapeutica; 1981 Mar 01; 2(9):597-600. PubMed ID: 7267676
    [Abstract] [Full Text] [Related]

  • 33. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B, Walzl M, Lechner P, Lechner H, Cesnik H.
    Wien Med Wochenschr; 1993 Mar 01; 143(22):563-70. PubMed ID: 8154130
    [Abstract] [Full Text] [Related]

  • 34. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease.
    Belfiglio A, Traietti P, Bologna E, Salvo G.
    Clin Ther; 1989 Mar 01; 11(4):479-84. PubMed ID: 2776165
    [Abstract] [Full Text] [Related]

  • 35. [On the behavior of lipidemia, blood viscosity and arterial flow of the limbs after oral lipid loading. Observations in subjects with peripheral obliterating arteriopathies].
    Bartoli V, Dorigo B, Ponzeveroni A, Barletta O.
    Mal Cardiovasc; 1969 Mar 01; 10(4):651-62. PubMed ID: 5405783
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical value of hemorrheology in peripheral arterial occlusive diseases].
    Sciannameo F, Francucci M, Cao PG, Giustozzi G, Valentini M, Tockner M, Sassano L, Grasselli A.
    Ric Clin Lab; 1983 Mar 01; 13 Suppl 3():417-22. PubMed ID: 6673023
    [Abstract] [Full Text] [Related]

  • 37. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H.
    Fortschr Med; 1980 Feb 21; 98(7):257-60. PubMed ID: 6767648
    [Abstract] [Full Text] [Related]

  • 38. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y, Satoh K, Kitadai M, Izumi Y, Takahashi T.
    Arzneimittelforschung; 1997 Aug 21; 47(8):900-4. PubMed ID: 9296274
    [Abstract] [Full Text] [Related]

  • 39. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM.
    Med Welt; 1975 Mar 07; 26(10):446-55. PubMed ID: 1123988
    [No Abstract] [Full Text] [Related]

  • 40. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J, Latza R, Pruss A, Kiesewetter H, Jung F, Meier C, Schimetta W.
    Clin Hemorheol Microcirc; 2000 Mar 07; 22(1):53-65. PubMed ID: 10711822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.